Tobacco Control

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

Tobacco Control 2006;15(Supplement 1 ):i3-i4; doi:10.1136/tc.2005.014464
Copyright © 2006 by the BMJ Publishing Group Ltd.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Maziak, W
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Maziak, W
Related Collections
Right arrow Health effects of tobacco use

EDITORIAL

On the gains of seeding tobacco research in developing countries

W Maziak1, M Arora2, K S Reddy3, Z Mao4 on behalf of researchers from developing countries participating in the Fogarty International Center's "International Tobacco Research and Capacity Building Program"

1 Syrian Center for Tobacco Studies, Syria
2 Health Related Information Dissemination Amongst Youth, India
3 All India Institute of Medical Sciences, India
4 Sichuan University, China

Correspondence to:
Wasim Maziak
PO Box 16542, Aleppo, Syrian Arab Republic; maziak@scts-sy.org

Keywords: developing countries; Fogarty International Center

The first 150 words of the full text of this article appear below.

A question central to the theme of this supplement to Tobacco Control is "why seed tobacco research in developing countries?" Arguably, research done in advanced institutions can provide answers to most questions regarding the hazards of smoking and ways to combat its spread. Indeed, do we need to repeat in developing countries expensive and lengthy cohort studies about the link between smoking and cancer? Or should we investigate addiction neurobiology in every population to better understand and treat it? Obviously, there may be differences in cancer risk or addiction neurobiology between populations, but are these of a sufficient magnitude and relevance to tobacco control to justify establishing such costly research programmes in developing countries. These are justified arguments, yet the question at hand is of much broader nature.


LOCAL DATA ESSENTIAL
We have learned through the years that the smoking epidemic follows a predictable course in most populations, thus requiring fairly similar intervention . . . [Full text of this article]







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2006 by the BMJ Publishing Group Ltd.